Academic literature on the topic 'Glutamate'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Glutamate.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Glutamate"
Ishikawa, Makoto. "Abnormalities in Glutamate Metabolism and Excitotoxicity in the Retinal Diseases." Scientifica 2013 (2013): 1–13. http://dx.doi.org/10.1155/2013/528940.
Full textMatthews, D. E., M. A. Marano, and R. G. Campbell. "Splanchnic bed utilization of glutamine and glutamic acid in humans." American Journal of Physiology-Endocrinology and Metabolism 264, no. 6 (June 1, 1993): E848—E854. http://dx.doi.org/10.1152/ajpendo.1993.264.6.e848.
Full textWelbourne, Tomas, and Itzhak Nissim. "Regulation of mitochondrial glutamine/glutamate metabolism by glutamate transport: studies with 15N." American Journal of Physiology-Cell Physiology 280, no. 5 (May 1, 2001): C1151—C1159. http://dx.doi.org/10.1152/ajpcell.2001.280.5.c1151.
Full textDarmaun, D., D. E. Matthews, and D. M. Bier. "Glutamine and glutamate kinetics in humans." American Journal of Physiology-Endocrinology and Metabolism 251, no. 1 (July 1, 1986): E117—E126. http://dx.doi.org/10.1152/ajpendo.1986.251.1.e117.
Full textWelbourne, T. C., K. Horton, and M. J. Cronin. "Growth hormone and renal glutamine and glutamate handling." Journal of the American Society of Nephrology 2, no. 7 (January 1992): 1171–77. http://dx.doi.org/10.1681/asn.v271171.
Full textVaughn, P. R., C. Lobo, F. C. Battaglia, P. V. Fennessey, R. B. Wilkening, and G. Meschia. "Glutamine-glutamate exchange between placenta and fetal liver." American Journal of Physiology-Endocrinology and Metabolism 268, no. 4 (April 1, 1995): E705—E711. http://dx.doi.org/10.1152/ajpendo.1995.268.4.e705.
Full textNissim, I., B. States, M. Yudkoff, and S. Segal. "Characterization of amino acid metabolism by cultured rat kidney cells: study with 15N." American Journal of Physiology-Renal Physiology 253, no. 6 (December 1, 1987): F1243—F1252. http://dx.doi.org/10.1152/ajprenal.1987.253.6.f1243.
Full textLow, S. Y., P. M. Taylor, H. S. Hundal, C. I. Pogson, and M. J. Rennie. "Transport of l-glutamine and l-glutamate across sinusoidal membranes of rat liver. Effects of starvation, diabetes and corticosteroid treatment." Biochemical Journal 284, no. 2 (June 1, 1992): 333–40. http://dx.doi.org/10.1042/bj2840333.
Full textTa, T. C., F. D. H. Macdowall, M. A. Faris, and K. W. Joy. "Metabolism of nitrogen fixed by root nodules of alfalfa (Medicago sativa L.): I. Utilization of [14C, 15N]glutamate and [14C, 15N]glutamine in the synthesis of γ-aminobutyrate." Biochemistry and Cell Biology 66, no. 12 (December 1, 1988): 1342–48. http://dx.doi.org/10.1139/o88-155.
Full textMoores, R. R., P. R. Vaughn, F. C. Battaglia, P. V. Fennessey, R. B. Wilkening, and G. Meschia. "Glutamate metabolism in fetus and placenta of late-gestation sheep." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 267, no. 1 (July 1, 1994): R89—R96. http://dx.doi.org/10.1152/ajpregu.1994.267.1.r89.
Full textDissertations / Theses on the topic "Glutamate"
Boulland, Jean-Luc. "Recycling the amino acid neurotransmitter glutamate in the CNS : l'alchimie du glutamate et de la glutamine." Paris 6, 2004. http://www.theses.fr/2004PA066017.
Full textCabré, Segura Gisela. "New photopharmacological tools for the light-induced control of neuronal signalling." Doctoral thesis, Universitat Autònoma de Barcelona, 2019. http://hdl.handle.net/10803/668303.
Full textThe main objective of neuroscience is the study and control of neuronal systems. Nowadays, this area is being revolutionised by the use of photoresponsive small molecules, a field known as photopharmacology. By enabling remote activation of drugs with light, photopharmacology seeks to tackle some of the main challenges faced by conventional pharmacology, such as poor drug selectivity and side effects.1 Three main strategies have been derived in this area: photocaged ligands (CL), freely diffusing prodrugs the effect of which is triggered by removing photolabile protecting groups upon illumination; photochromic ligands (PCL), which allow reversible modulation of the response of bioactive molecules through photoisomerisation of appended light-responsive moieties; and photoswitched tethered ligands (PTL), a special case of PCLs that are covalently attached to the therapeutic receptor. Although these approaches have proven to be successful for a variety of therapeutic targets in vitro and in vivo, several challenges still remain in the field of photopharmacology. Therefore, in this work we have aimed at the investigation of new photopharmacological strategies that overcome some of the weaknesses of the tools developed so far. We have particularly focused on the photocontrol of ionotropic glutamate receptors (iGluRs), which play a key role in the modulation of neuronal excitability. The novel photopharmacological tools developed along this thesis consist in: (i) a PTL based on push-pull-substituted azobenzene photoswitches that responds to two-photon excitation with NIR light. (ii) a non-destructive caged ligand that enable irreversible and quantitative conversion from the inactive to the active state, thus performing in a similar fashion as CLs but without by-product generation. (iii) a PCL based on C2-bridged azobenzenes which displays a thermodynamically stable inactive form that selectively turns into the biologically-active state when irradiated. This thesis reports the synthesis, photochemical characterisation and biological activity evaluation of these three novel photopharmacological approaches.
Scott-Taggart, Catherine Patricia. "Inhibition of glutamine production increases glutamate metabolism via the GABA shunt." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp03/MQ27542.pdf.
Full textBarel, Itai. "The regulation of glutamine synthetase and glutamate synthase in Schizosaccharomyces pombe." Thesis, University of Cambridge, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.279649.
Full textSilva, Jackeline Thaís da. "Aminoácidos limitantes para o desempenho de bezerros leiteiros: avaliação de teores ótimos e via de fornecimento." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/11/11139/tde-11112014-163521/.
Full textThe aim in this work was to evaluate the concentration of essential amino acids (Lysine and Methionine) considered in the literature as ideal, according to feeding route (milk replacer or starter concentrate), and its association with the supplementation of glutamate and glutamine to calves in two feeding systems: conventional or step-down. In the first study, the chemical composition was analyzed and in amino acids of main milk replacer marketed in Brazil. In the second and third studies, 45 Holstein calves were used, in randomized blocks distributed in treatments: 1) Control: without supplementation; 2) Supplementation with lysine and methionine to reach consumption of 17 and 5.3 g/d, respectively, with correction based on the analysis basis of the milk replacer, 3) Supplementation of lysine and methionine to reach consumption of 17 and 5.3 g/d, respectively, with correction based on the analysis basis of starter concentrate. The difference between the experiments was the feeding system applied to the calves: in the second study, the animals received 6 L/d of milk replacer; while in the third study, the animals were submitted to the step-down system (4L/d until the 2nd week; 8L/d of the 3nd to 6th week; 4L/d of the 7th to 8th week). In the fourth study, the same experimental design was used to evaluate, in a conventional feeding system, treatments: 1) Control: without supplementation; 2) AminoGut 0.6%: milk replacer supplemented with Lysine and Methionine, to reach consumption 17 and 5.3g/d, respectively + 0.6% product containing 10% of glutamate and glutamine; 3) AminoGut 1%: milk replacer supplemented with Lysine and Methionine to reach consumption 17 and 5.3g/d + 0.6% product containing 10% of glutamate and glutamine. The animals were housed in individual hutches, with free access to water and starter concentrate. The consumption of starter concentrate and fecal scores of animals were monitored daily. Body growth was weighed and measured weekly. In weeks 2, 4, 6, 8 and 10, blood samples were collected to determine the metabolites as markers of protein status of animals (albumin, total protein, N-urea), energy status (glucose and BHBA), bone growth (alkaline phosphatase) and muscular growth (creatinine). The composition of amino acids of the milk replacer marketed in Brazil was lower than expected for diet that replaces the whole milk. In study 2 and 3, the supplementation of the milk replacer or starter concentrate with lysine and methionine resulted in no benefit on dairy calves performance or metabolism. In study 4 the supplementation of the milk replacer with lysine and methionine in association with glutamate and glutmine had no effect on performance, gut health nor metabolism of dairy calves.
Apricò, Karina 1977. "[3H](2S,4R)-4-methylglutamate as a novel radioligand for brain glutamate transporters." Monash University, Dept. of Pharmacology, 2003. http://arrow.monash.edu.au/hdl/1959.1/5497.
Full textGirard, Benoît. "Impact de l’activation du récepteur mGlu7 dans l’épilepsie." Thesis, Montpellier, 2018. http://www.theses.fr/2018MONTT038.
Full textEpilepsy affects millions of patients worldwide. The available treatments are symptomatic, they treat seizures without preventing the progression of the disease and have heavy side effects. The discovery of new therapeutic targets and new compounds is therefore essential to overcome the limitations of current therapeutic strategies. Previous studies have demonstrated substantial involvement of the mGlu7 receptor in modulating not only excitability but also hypersynchronization of neural networks, two crucial factors affecting epileptic seizures. These discoveries were at the origin of a first publication that I completed at the beginning of my thesis (Tassin, Girard et al., 2016).Using a new mGlu7 receptor agonist, LSP2-9166, in my thesis I then studied the impact of this receptor in different epilepsy models in mice. Two complementary models were used: kindling, a chemical model induced by pentylenetetrazol (PTZ) which sensitizes the brain to induce generalized tonic-clonic seizures, and intra-hippocampal injection of kainate, mimicking mesial temporal lobe epilepsy in humans.At first, I observed an attenuation of the progression of the seizures severity in the PTZ kindling model, under the activation of the mGlu7 receptor. This effect was correlated with weaker inflammation, and microglial and astrocytic activation. In the intra-hippocampal injection model of KA, considered as drug-resistant, activation of the mGlu7 receptor during the epileptogenesis period increased the duration of interictal periods and decreased the duration of seizures as well as neuronal reorganization. Once chronic seizures were established, acute activation of the mGlu7 receptor decreased the number of seizures as strongly as diazepam, commonly used in clinical settings. Finally, chronic injections of LSP2-9166 into naive (non epileptic) animals do not generate any detectable cognitive or behavioral deficits or changes in mGlu7 receptor mRNA level. The activation of the mGlu7 receptor thus presents a strategic target in our two models.This work provides a better understanding of the role of the mGlu7 receptor in epileptogenesis. It participates in the search for future more adequate treatments
Sachidhanandam, Shankar. "Rôle des récepteurs kaïnate dans le transfert d'information dans l'hippocampe." Bordeaux 2, 2007. http://www.theses.fr/2007BOR21433.
Full textKainate receptors (KAR) are ionotropic glutamate receptors implicated in the regulation of synaptic transmission and neuronal excitability. At the mossy fiber (Mf) synapse, KARs can be expressed both pre and postsynaptically. In this study, we examined physiological role of KARs in information transfer at the Mf-CA3 pyramidal cell synapse in the mouse hippocampus. We show that KARs can operate in dual mode, by a direct ionotropic action via GluR6, and an indirect G-protein coupled mechanism requiring the binding of glutamate to KA2, to inhibit the slow afterhyperpolarization (IsAHP), hence enhancing neuronal excitability. Using mice deficient for the various KAR subunits, we show that postsynaptic KARs shape the waveform of unitary EPSPs, and pre and postsynaptic KARs act together to amplify unitary EPSPs, triggering spike discharge under conditions of sustained mossy fiber activity. KARs improve timing precision within a frequency range of 3 to 50 Hz and modulation of IsAHP by KA2 facilitates spike discharge in prolonged stimulus trains. KARs are permissive to the induction of LTP at the associative/commissural input. Physiological patterns of afferent input reproduce the output obtained with controlled stimulus inputs. Hence KARs act as amplifiers of synaptic transmission, to enhance the transfer of information at the Mf-CA3 pyramidal cell synapse
Martin, Emily P. "Expression of glutamate dehydrogenase and glutamine synthetase RNA in preimplantation mouse embryos." Virtual Press, 1999. http://liblink.bsu.edu/uhtbin/catkey/1117849.
Full textDepartment of Biology
Saito, Kelly Cristina. "Envolvimento de Rac1 na excitotoxicidade induzida por NMDA na retina de ratos." Universidade de São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/42/42134/tde-10022012-132908/.
Full textOveractivation of NMDA receptors has been described to trigger neuronal death that occurs in diseases such as glaucoma. It is possible that the combination of subunits (NR2A-D) activate intracellular signaling pathways that result in death or survival. Our aim was to investigate the involvement of NR2 subunits and Rac1, a member of Rho GTPase family, in retinal neuronal death. Glutamate-induced neuronal death in vitro was reduced after Rac1 inhibition and by NR2B blocking, but not NR2C/D subunits. Similar results were obtained in vivo after NMDA intravitreous injection, although active Rac1 was mainly detected in Müller glia processes, and it was inhibited by NR2B blockade. In addition, TNF-α level after NMDA injection were reduced by NR2B blocking and Rac1. Thus, our results suggest that excitotoxicity via NR2B/NMDA receptors activate Rac1 in Müller glia cells, which in turn controls the TNF-α production that triggers retinal ganglion cell death.
Books on the topic "Glutamate"
Schousboe, Arne, and Ursula Sonnewald, eds. The Glutamate/GABA-Glutamine Cycle. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-45096-4.
Full textAlton, Meister, ed. Glutamate, glutamine, glutathione, and related compounds. Orlando, Fla: Academic Press, 1985.
Find full textP, Ottersen O., and Storm-Mathisen Jon, eds. Glutamate. Amsterdam: Elsevier, 2000.
Find full textBurger, Corinna, and Margaret Jo Velardo, eds. Glutamate Receptors. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9077-1.
Full textHerman, Barbara H., Jerry Frankenheim, Raye Z. Litten, Philip H. Sheridan, Forrest F. Weight, and Stephen R. Zukin. Glutamate and Addiction. New Jersey: Humana Press, 2002. http://dx.doi.org/10.1385/1592593062.
Full textGereau, Robert W., and Geoffrey T. Swanson, eds. The Glutamate Receptors. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-055-3.
Full textH, Herman Barbara, and Frankenheim Jerry, eds. Glutamate and addiction. Totowa, N.J: Humana Press, 2003.
Find full textBaskys, Andrius. Metabotropic glutamate receptors. Austin: R.G. Landes Co., 1994.
Find full textPavlovic, Zoran M., ed. Glutamate and Neuropsychiatric Disorders. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-87480-3.
Full textConn, P. Jeffrey, and Jitendra Patel, eds. The Metabotropic Glutamate Receptors. Totowa, NJ: Humana Press, 1994. http://dx.doi.org/10.1007/978-1-4757-2298-7.
Full textBook chapters on the topic "Glutamate"
Sanzone, Marla. "Glutamate." In Encyclopedia of Clinical Neuropsychology, 1160–62. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-79948-3_1661.
Full textSanzone, Marla. "Glutamate." In Encyclopedia of Clinical Neuropsychology, 1–3. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56782-2_1661-2.
Full textSanzone, Marla. "Glutamate." In Encyclopedia of Clinical Neuropsychology, 1587–89. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_1661.
Full textManji, Husseini K., Jorge Quiroz, R. Andrew Chambers, Anthony Absalom, David Menon, Patrizia Porcu, A. Leslie Morrow, et al. "Glutamate." In Encyclopedia of Psychopharmacology, 559. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_1695.
Full textNistri, Andrea. "Glutamate." In Neurotransmitter Actions in the Vertebrate Nervous System, 101–23. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4684-4961-7_4.
Full textYuen, Eunice. "Glutamate." In Encyclopedia of Autism Spectrum Disorders, 1–2. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4614-6435-8_102077-1.
Full textDuce, Ian R. "Glutamate." In Comparative Invertebrate Neurochemistry, 42–89. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4615-9804-6_2.
Full textMurala, Sireesha, Aditya Boddu, and Pradeep C. Bollu. "Glutamate." In Neurochemistry in Clinical Practice, 91–107. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-07897-2_5.
Full textYuen, Eunice. "Glutamate." In Encyclopedia of Autism Spectrum Disorders, 2258. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-319-91280-6_102077.
Full textÖz, Gülin, David A. Okar, and Pierre-Gilles Henry. "Glutamate-Glutamine Cycle and Anaplerosis." In Neural Metabolism In Vivo, 921–46. Boston, MA: Springer US, 2011. http://dx.doi.org/10.1007/978-1-4614-1788-0_32.
Full textConference papers on the topic "Glutamate"
Syafiie, S., and I. H. Mustafa. "Single compartment modeling glutamine-glutamate-GABA system in neuron." In 2016 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES). IEEE, 2016. http://dx.doi.org/10.1109/iecbes.2016.7843506.
Full textRahman, M. M., T. Yamazaki, T. Ikeda, M. Ishida, and K. Sawada. "Development of a glutamate biosensor based on glutamate oxidase using smart-biochips." In TRANSDUCERS 2009 - 2009 International Solid-State Sensors, Actuators and Microsystems Conference. IEEE, 2009. http://dx.doi.org/10.1109/sensor.2009.5285556.
Full textSakinyte-Urbikiene, Ieva, Vidute Gureviciene, and Julija Razumiene. "Amperometric Biosensing of L-Glutamate Using Reduced Graphene Oxide and Glutamate Oxidase." In Eurosensors 2023. Basel Switzerland: MDPI, 2024. http://dx.doi.org/10.3390/proceedings2024097005.
Full textMacpherson, IR, E. Dornier, N. Rabas, E. Rainero, and JC Norman. "Abstract P6-01-06: Glutamine metabolism drives breast cancer invasion by providing a source of extracellular glutamate to activate the GRM3 metabotropic glutamate receptor." In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-p6-01-06.
Full textBernal-Martínez, Juan. "L-glutamate Receptor In Paramecium." In MEDICAL PHYSICS: Eighth Mexican Symposium on Medical Physics. AIP, 2004. http://dx.doi.org/10.1063/1.1811853.
Full textLee, Gija, Seokkeun Choi, Sungwook Kang, Samjin Choi, Jeonghoon Park, Dong Hyun Park, Youngho Park, Kyungsook Kim, Bermseok Oh, and Hunkuk Park. "Changes in Extracellular Glutamate Release on Repetitive Transient Occlusion in Global Ischemia Model." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206602.
Full textMohan, A., J. Gall, S. Nair, and P. Kalivas. "Glutamate Dynamics in the PFC-NAC Synapse." In ASME 2006 International Mechanical Engineering Congress and Exposition. ASMEDC, 2006. http://dx.doi.org/10.1115/imece2006-15401.
Full textKotake, Naoki, Takafumi Suzuki, Osamu Fukayama, and Kunihiko Mabuchi. "A flexible parylene-based glutamate sensor." In 5th International IEEE/EMBS Conference on Neural Engineering (NER 2011). IEEE, 2011. http://dx.doi.org/10.1109/ner.2011.5910550.
Full textGao, Yong. "UASB Treatment of Monosodium Glutamate Wastewater." In 2010 4th International Conference on Bioinformatics and Biomedical Engineering (iCBBE). IEEE, 2010. http://dx.doi.org/10.1109/icbbe.2010.5516404.
Full textXiao, Guihua, Yilin Song, Song Zhang, Shengwei Xu, Lili Yang, Huiren Xu, and Xinxia Cai. "Microelectrode arrays studies of glutamate excitatory pathway in hippocampus CA3 by offside KCl and glutamate stimulating." In 2017 8th International IEEE/EMBS Conference on Neural Engineering (NER). IEEE, 2017. http://dx.doi.org/10.1109/ner.2017.8008333.
Full textReports on the topic "Glutamate"
Niu, Li. Glutamate Receptor Aptamers and ALS. Fort Belvoir, VA: Defense Technical Information Center, January 2008. http://dx.doi.org/10.21236/ada481452.
Full textRisbrough, Victoria. Glutamate Transmission Enhancement for Treatment of PTSD. Fort Belvoir, VA: Defense Technical Information Center, March 2009. http://dx.doi.org/10.21236/ada506358.
Full textMichaelis, Elias K. Molecular Characteristics of Membrane Glutamate Receptor-Ionophore Interaction. Fort Belvoir, VA: Defense Technical Information Center, October 1988. http://dx.doi.org/10.21236/ada201954.
Full textSurmeier, James. Glutamate Signaling and Mitochnodrial Dysfunction in Models of Parkinson's Disease. Fort Belvoir, VA: Defense Technical Information Center, December 2012. http://dx.doi.org/10.21236/ada602445.
Full textSurmeier, D. J. Glutamate Signaling and Mitochondrial Dysfunction in Models of Parkinson's Disease. Fort Belvoir, VA: Defense Technical Information Center, March 2014. http://dx.doi.org/10.21236/ada604089.
Full textStern, Michael. Group II Metabotropic Glutamate Receptors as Potential Pharmaceutical Targets for Neurofibroma Formation. Fort Belvoir, VA: Defense Technical Information Center, February 2010. http://dx.doi.org/10.21236/ada542280.
Full textStern, Michael. Group II Metabotropic Glutamate Receptors as Potential Pharmaceutical Targets for Neurofibroma Formation. Fort Belvoir, VA: Defense Technical Information Center, February 2011. http://dx.doi.org/10.21236/ada542347.
Full textFromm, Hillel, and Joe Poovaiah. Calcium- and Calmodulin-Mediated Regulation of Plant Responses to Stress. United States Department of Agriculture, September 1993. http://dx.doi.org/10.32747/1993.7568096.bard.
Full textAkanji, Bukunmi Abongwa. Functional expression of a glutamate-gated chloride channel (GLC-3) from adult Brugia malayi. Ames (Iowa): Iowa State University, January 2018. http://dx.doi.org/10.31274/cc-20240624-771.
Full textLiu, Ya F. Molecular Analysis of the Common Signaling Mechanism of Neuronal Death Induced by Glutamate and Mutated Huntington. Fort Belvoir, VA: Defense Technical Information Center, March 2001. http://dx.doi.org/10.21236/ada393700.
Full text